Melanocortin receptor agonists

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/437 (2006.01) A61K 31/4164 (2006.01) A61K 31/47 (2006.01) C07D 233/88 (2006.01) C07D 401/12 (2006.01) C07D 471/02 (2006.01) C07D 471/04 (2006.01)

Patent

CA 2410597

Certain novel compounds and derivatives thereof are agonists of the human melanocortin receptor(s) and, in particular, are selective agonists of the human melanocortin-4 receptor (MC-4R). They are therefore useful for the treatment, control, or prevention of diseases and disorders responsive to the activation of MC-4R, such as obesity, diabetes, sexual dysfunction, including erectile dysfunction and female sexual dysfunction.

L'invention concerne certains nouveaux composés et dérivés de ceux-ci qui sont des agonistes d'au moins un récepteur de la mélanocortine humaine et, en particulier, qui sont des agonistes sélectionnés du récepteur 4 de la mélanocortine humaine (MC-4R). Ceux-ci sont, par conséquent, utiles pour le traitement, le contrôle ou la prévention de maladies et de troubles répondant à l'activation du MC-4R, tels que l'obésité, les diabètes, une dysfonction sexuelle, notamment une dysfonction érectile, ainsi qu'une dysfonction sexuelle féminine.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Melanocortin receptor agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Melanocortin receptor agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Melanocortin receptor agonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1854521

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.